Approval · Notice of Compliance 38000 · 2026
SPC-FENOFIBRATE E: Notice of Compliance 38000
Issued July 28, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 38000
- Date
- July 28, 2026
- Company
- Sun Pharma Canada Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Update to Product Monograph (to align with CRP approved PM)
- Canadian reference product
- LIPIDIL EZ (Fournier Pharma Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SPC-FENOFIBRATE E | Not yet assigned | — |
Medicinal ingredients
- FENOFIBRATE 145 MG per TAB